TABLE 3.
Strain | ESBL | MLST | PG | Plasmid replicon type |
MIC |
bla gene product | Transfer | |||||
ATM | FEP | CTX | CAZ | CZO | FOX | |||||||
EC-1 | − | ST51 | B2 | FIA,FIB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-3 | − | ST2 | B2 | ND | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-16 | − | ST1 | B1 | FrepB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-18 | − | ST51 | B2 | K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-21 | − | ST2 | A | FrepB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-23 | − | ST8 | B2 | FIB,FrepB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-26 | − | ST2 | B2 | K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-28 | − | ST117 | A | FIB,FrepB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-33 | − | ST45 | B2 | FIB,FrepB,K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
EC-35 | − | ST730 | A | ND | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | OXA-30 | − |
EC-42 | − | ST95 | A | ND | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | SHV-42 | + |
EC-49 | − | ST51 | B1 | K | ≤2 | ≤2 | ≤1 | ≤1 | ≤4 | ≤8 | TEM-1 | + |
PG, phylogenetic group; MIC, minimum inhibitory concentration.